With disease-modifying therapy for Alzheimer's disease (AD) moving ever closer, there is increasing focus on diagnostic methods to identify the condition at an early stage. In neurological diseases, early medical intervention, starting before deterioration of brain function, is preferable. This ...
Please Login to read the full article.
